Epilepsy Foundation
Board Interlocks (5 shared directors)
Giving Philosophy
As a direct service delivery charity, its core philosophy is to empower individuals affected by epilepsy through comprehensive support, education, and advocacy, rather than providing external grants to other organisations. Its impact is achieved through its programs and services designed to meet the needs of the epilepsy community.
Tips for Applicants
As the Epilepsy Foundation is primarily a service delivery organisation, it does not offer external grants. Individuals, families, and organisations should engage by accessing their direct support services, education programs, and advocacy resources. Opportunities for partnership may exist for specific research or awareness initiatives aligned with their mission.
Programs & Opportunities (3)
This grant, in collaboration with Syngap Research Fund Australia, sought Expressions of Interest (EOI) from investigators for SYNGAP-1 research, focusing on novel therapeutic approaches or clinical trial readiness projects for SYNGAP-1.
Grants for medical and psycho-social research into epilepsy including pre-clinical, translational, clinical and social/community research. Must be for organisations with DGR Item 1 and Tax Concession Charity status.
This fund supports innovative and high-quality research aimed at curing epilepsy or reducing its impact on people's lives, and finding new and improved treatments. It supports researchers, universities, research institutes, and hospitals, with applications open to organisations holding Deductible Gift Recipient (DGR) Item 1 and Tax Concession Charity (TCC) status.
Financial History (7 years)
| Year | Revenue | Expenses | Assets | Surplus |
|---|---|---|---|---|
| 2023 | $11.1M | $11.1M | $17.9M | $62K |
| 2022 | $9.9M | $10.0M | $18.6M | $-103,112 |
| 2021 | $8.7M | $6.9M | $18.7M | $1.8M |
| 2020 | $6.5M | $6.3M | $14.6M | $178K |
| 2019 | $5.0M | $4.7M | $8.3M | $299K |
| 2018 | $4.1M | $4.0M | $6.1M | $134K |
| 2017 | $4.2M | $4.2M | $5.9M | $24K |
Community Evidence
External EvidenceIdentity
- GS ID
- AU-ABN-75967571784
- ABN
- 75967571784
- Sector
- health
- Financial Year
- 2023
Focus Areas
Board & Leadership (8)
- board member
- board member
- board member
- board member
- board member
- board member
- board member
- chair
Financials
- Revenue
- $11.1M
- Assets
- $17.9M
Method
- Match Confidence
- registry
- Cross-references
- 2 datasets
- Match Key
- ABN
- Relationships
- 35
Matched by Australian Business Number (ABN) — high confidence. This entity was found across multiple government datasets using the same ABN.
Data Sources
JusticeHub
External LinkThis entity is also tracked in JusticeHub with 0 interventions and 0 evidence records.
External ecosystem profile linked from GrantScope for additional context. JusticeHub content is maintained separately.
View on JusticeHubLocation Intelligence
- Postcode
- 3126
- Locality
- CAMBERWELL EAST
- Remoteness
- Major Cities of Australia
- SEIFA Disadvantage
- Decile 10/10
- LGA
- Boroondara
- SA2 Region
- Surrey Hills (West) - Canterbury
- Entities in Area
- 124
Disability Market Context
NDIS LayerThis organisation shows disability-related delivery signals. The strategic question is whether it sits inside a resilient market, a thin market, or a captured market where large providers take most of the money and local alternatives are scarce.